Results for tag: "Pruritis Drug"

Pruritis is a common skin condition characterized by an intense itching sensation. Dermatological drugs are used to treat this condition, and the pruritis drug market is a subset of the larger dermatological drug market. Pruritis drugs are typically divided into two categories: topical and systemic. Topical drugs are applied directly to the skin and are used to reduce inflammation and itching. Systemic drugs are taken orally or injected and are used to treat more severe cases of pruritis. The pruritis drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and Johnson & Johnson. Other companies such as Galderma, Mylan, and Sun Pharmaceuticals also offer pruritis drugs. Show Less Read more